美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aspire Biopharma Holdings Inc.

0.4530

-0.0341-7.00%

成交量：15.80萬

成交額：7.61萬

市值：2,215.22萬

市盈率：-309.85

高：0.5080

開：0.4900

低：0.4500

收：0.4871

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Aspire Biopharma Holdings Inc.

交易所：

NASDAQ

成立時間：

2021

員工人數：

- -

公司地址：

194 Candelero Drive,Suite 223,Humacao,Puerto Rico,United States

官網：

http://www.aspirebiolabs.com

郵編：

00791

電話：

傳真：

- -

簡介：

Aspire Biopharma Holdings, Inc.成立於2021年2月9日，是一家特拉華州公司。該公司是一家早期生物製藥公司，從事開發和營銷新型遞送機制顛覆性技術的業務，最初用於“不傷害”藥物。迄今為止，Aspire已開發並獲得了顛覆性技術，這些技術是一種新型可溶性製劑，旨在解決緊急情況、藥物功效、劑量管理和響應時間等問題。Aspire的重點是開發任何數量的可溶性、PH中性、速效粉末或顆粒形式的產品，允許產品的快速舌下吸收。

董事

名稱

職位

Bruce Hack

Executive Chairman and Director

Jack Tretton

Chief Executive Officer and Director

Julie Uhrman

Independent Director

Kyle Campbell

Independent Director

Peter Blacklow

Independent Director

股東

名稱

職位

Jack Tretton

Chief Executive Officer and Director

Michael Olson

Chief Financial Officer

Bruce Hack

Executive Chairman and Director

Gabriel Schillinger

President

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ASBP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":0.453,"timestamp":1745870400000,"preClose":0.4871,"halted":0,"volume":157969,"delay":0,"floatShares":31062729,"shares":48901000,"eps":-0.001462,"marketStatus":"盤前交易","change":-0.0341,"latestTime":"04-29 04:20:03 EDT","open":0.49,"high":0.508,"low":0.45,"amount":76089.556176,"amplitude":0.119072,"askPrice":0.5753,"askSize":100,"bidPrice":0.3658,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.001462,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745933400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.465,"postHourTrading":{"tag":"盘后","latestPrice":0.4882,"preClose":0.453,"latestTime":"18:27 EDT","volume":512,"amount":247.5556,"timestamp":1745879231403},"volumeRatio":1.8735803480829492},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","floatShares":31062729,"roa":"--","roe":"--","lyrEps":-0.00081,"volumeRatio":1.8735803480829492,"shares":48901000,"dividePrice":0,"high":0.508,"amplitude":0.119072,"preClose":0.4871,"low":0.45,"week52Low":0.4011,"pbRate":"-27.64","week52High":15.8,"institutionHeld":0,"latestPrice":0.453,"eps":-0.001462,"divideRate":0,"volume":157969,"delay":0,"ttmEps":-0.001462,"open":0.49,"prevYearClose":11.5,"prevWeekClose":0.4871,"prevMonthClose":0.5826,"prevQuarterClose":0.5826,"fiveDayClose":0.495,"twentyDayClose":0.64,"sixtyDayClose":11.8},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1860544308,"yearFounded":2021,"address":"194 Candelero Drive,Suite 223,Humacao,Puerto Rico,United States","zipCode":"00791","officePhone":"415 592 7399"},"stockCompanyDetail":{"websiteUrl":"http://www.aspirebiolabs.com","stockEarnings":[{"period":"1week","weight":-0.0848},{"period":"1month","weight":-0.2922},{"period":"3month","weight":-0.9613},{"period":"6month","weight":-0.9604},{"period":"1year","weight":-0.9594},{"period":"ytd","weight":-0.9606}],"compareEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0888},{"period":"6month","weight":-0.0503},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0601}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Aspire Biopharma Holdings, Inc.成立於2021年2月9日，是一家特拉華州公司。該公司是一家早期生物製藥公司，從事開發和營銷新型遞送機制顛覆性技術的業務，最初用於“不傷害”藥物。迄今為止，Aspire已開發並獲得了顛覆性技術，這些技術是一種新型可溶性製劑，旨在解決緊急情況、藥物功效、劑量管理和響應時間等問題。Aspire的重點是開發任何數量的可溶性、PH中性、速效粉末或顆粒形式的產品，允許產品的快速舌下吸收。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.045588},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.290368},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.201784},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.069589},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.001658},{"month":6,"riseRate":1,"avgChangeRate":0.002239},{"month":7,"riseRate":0.666667,"avgChangeRate":0.003474},{"month":8,"riseRate":0.666667,"avgChangeRate":0.012669},{"month":9,"riseRate":0.666667,"avgChangeRate":0.030139},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.019111},{"month":11,"riseRate":0.666667,"avgChangeRate":0.004225},{"month":12,"riseRate":1,"avgChangeRate":0.002692}],"exchange":"NASDAQ","name":"Aspire Biopharma Holdings Inc.","nameEN":"Aspire Biopharma Holdings Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ASBP\",market:\"US\",,,undefined,":{"directors":[{"name":"Bruce Hack","position":"Executive Chairman and Director"},{"name":"Jack Tretton","position":"Chief Executive Officer and Director"},{"name":"Julie Uhrman","position":"Independent Director"},{"name":"Kyle Campbell","position":"Independent Director"},{"name":"Peter Blacklow","position":"Independent Director"}],"executives":[{"name":"Jack Tretton","position":"Chief Executive Officer and Director"},{"name":"Michael Olson","position":"Chief Financial Officer"},{"name":"Bruce Hack","position":"Executive Chairman and Director"},{"name":"Gabriel Schillinger","position":"President"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASBP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASBP","date":"2025-04-25","current":-36.428037,"percent":0.894737,"low":-107.647863,"twenty":-53.967461,"median":-44.487272,"eighty":-38.006872,"high":-28.792214,"avg":-46.609012,"sd":13.320157,"marketCap":23611087},"quantilePoints":[{"date":"2025-03-07","current":-61.718107,"twenty":-79.515888,"median":-61.718107,"eighty":-58.474317,"marketCap":40003023},{"date":"2025-03-14","current":-41.62384,"twenty":-63.871064,"median":-57.344015,"eighty":-54.828644,"marketCap":26978783},{"date":"2025-03-21","current":-49.388839,"twenty":-61.718107,"median":-55.259235,"eighty":-45.464716,"marketCap":32011722},{"date":"2025-03-28","current":-47.36506,"twenty":-59.766092,"median":-48.376949,"eighty":-45.613987,"marketCap":30699995},{"date":"2025-04-04","current":-38.75323,"twenty":-56.183571,"median":-46.367595,"eighty":-43.647619,"marketCap":25118177},{"date":"2025-04-11","current":-38.035578,"twenty":-55.34679,"median":-45.929755,"eighty":-40.946376,"marketCap":24653026},{"date":"2025-04-17","current":-39.57853,"twenty":-55.287942,"median":-45.474044,"eighty":-39.546954,"marketCap":25653101},{"date":"2025-04-25","current":-36.428037,"twenty":-53.967461,"median":-44.487272,"eighty":-38.006872,"marketCap":23611087}],"updateTime":1745914803617}}}